Outcome of Classical Hodgkin’s Lymphoma Treatment Based on High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Experience in the NI Pirogov Russian National Medical Center of Surgery

Outcome of Classical Hodgkin’s Lymphoma Treatment Based on High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Experience in the NI Pirogov Russian National Medical Center of Surgery

Aim. To estimate the long-term outcome of the programmed treatment of classical Hodgkin’s lymphoma (cHL) including high-dose chemotherapy (HDCT) and autologous hematopoietic stem cell transplantation (auto-HSCT) as well as the effect of various factors on the achieved results in a single-center stud...

Full description

Saved in:
Bibliographic Details
Main Authors: NE Mochkin, VO Sarzhevskii, YuN Dubinina, EG Smirnova, DA Fedorenko, AE Bannikova, DS Kolesnikova, VS Bogatyrev, NM Faddeev, VYa Mel’nichenko
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2018-07-01
Series:Клиническая онкогематология
Subjects:
high-dose chemotherapy
classical Hodgkin’s lymphoma
autologous hematopoietic stem cell transplantation
Online Access:http://bloodjournal.ru/wp-content/uploads/2018/06/4.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://bloodjournal.ru/wp-content/uploads/2018/06/4.pdf

Similar Items